Isoform-Selective Inhibition of the Human UDP-glucuronosyltransferase 2B7 by Isolongifolol Derivatives-Reference-Cited by-同舟云学术

Isoform-Selective Inhibition of the Human UDP-glucuronosyltransferase 2B7 by Isolongifolol Derivatives

Published:2007-05-01 Issue:11 Volume:50 Page:2655-2664
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bichlmaier Ingo¹,Kurkela Mika¹,Joshi Tanmaya¹,Siiskonen Antti¹,Rüffer Tobias¹,Lang Heinrich¹,Suchanová Bohumila¹,Vahermo Mikko¹,Finel Moshe¹,Yli-Kauhaluoma Jari¹

Affiliation:

1. Division of Pharmaceutical Chemistry, Faculty of Pharmacy, and Drug Discovery and Development Technology Center, University of Helsinki, FI-00014 Helsinki, Finland, Department of Chemistry, Indian Institute of Technology, Kanpur 208016 (UP), India, and Lehrstuhl für Anorganische Chemie, Institut für Chemie, Technische Universität Chemnitz, D-09111 Chemnitz, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm061204e

Reference49 articles.

1. Human SULT1A Genes: Cloning and Activity Assays of the SULT1A Promoters

2. GLUCURONIDATION AND THE UDP-GLUCURONOSYLTRANSFERASES IN HEALTH AND DISEASE

3. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†

4. Identification and Characterization of Functional Hepatocyte Nuclear Factor 1‐Binding Sites in UDP‐Glucuronosyltransferase Genes

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the synthesis of 5'-deoxynucleoside phosphonate analogs;Current Medicinal Chemistry;2021-11-11

2. Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping;Pharmacology & Therapeutics;2021-02

3. Herb–drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7;Toxicology and Applied Pharmacology;2014-05

4. Enantioselective Access to (−)-Ambrox®Starting fromβ-Farnesene;Helvetica Chimica Acta;2014-02

5. An Alternative Pathway to Ribonucleoside β-Hydroxyphosphonate Analogues and Related Prodrugs;Organic Letters;2013-09-09